Abstract

The Response Assessment in Neuro-Oncology Criteria (RANO) Working Group recently published updated guidelines for assessing response to therapy in high-grade gliomas.[1][1] The goal of the group continues to be the development of a standardized method of response assessment. These guidelines are

Highlights

  • The validity of a research article is based on how close the study results are to the truth

  • The application of the best evidence into clinical practice requires a transition from thinking about the sensitivity and specificity of a diagnostic test to the likelihood or probability of the patient having the disease

  • If the pretest probability is above the clinician’s inclusion threshold for disease diagnosis or below the exclusion threshold, no further diagnostic testing is necessary because there is a reasonable degree of certainty that the patient does or does not have the disease

Read more

Summary

Introduction

The validity of a research article is based on how close the study results are to the truth. The application of the best evidence into clinical practice requires a transition from thinking about the sensitivity and specificity of a diagnostic test to the likelihood or probability of the patient having the disease. The major modification proposed by the RANO guidelines is the assessment of increasing fluid-attenuated inversion recovery (FLAIR) signal intensity change as evidence of tumor progression.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.